Mississauga, Canada

Xiaoli Wang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Xiaoli Wang

Introduction: Xiaoli Wang is an accomplished inventor based in Mississauga, Canada, with a strong portfolio of four patents to her name. Her inventions primarily focus on the pharmaceutical field, specifically concerning formulations that improve the handling and application of pharmaceutical agents.

Latest Patents: Among her notable inventions are novel spill-resistant formulations that contain clays. These formulations integrate either a weak base or a weak acid as the pharmaceutical ingredient, accompanied by a liquid base, clay, and water-soluble cellulose ether. The innovative combination of clay and cellulose ether allows for a broader pH range within which the pharmaceutically active agent can be dispersed or dissolved. This advancement not only enhances the ease of preparation but also significantly improves the formulation process of pharmaceutical compositions.

Career Highlights: Xiaoli is currently employed at Taro Pharmaceuticals USA, Inc., where she leverages her expertise to develop groundbreaking pharmaceutical products. Her dedication to innovation has made a significant impact on the company's research and development efforts.

Collaborations: Throughout her career, Xiaoli has collaborated with esteemed colleagues such as Satish Asotra and Zoltan Bodor. These partnerships have enriched her work and contributed to the successful development of her patented inventions.

Conclusion: With her impressive array of patents and a commitment to pharmaceutical innovation, Xiaoli Wang continues to be a valuable asset to Taro Pharmaceuticals and the broader scientific community. Her work exemplifies the vital role of inventors in advancing technology and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…